Dr Todd A. Hardy

Cited by

	All	Since 2019
Citations	4990	3762
h-index	32	28
i10-index	51	47

740

370

185

555

2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202416 12 10 13 23 11 21 29 31 39 50 53 68 118 137 212 314 456 530 706 730 669 649

Public access

View all

21 articles

5 articles

available

not available

Based on funding mandates

Co-authors

Michael BarnettThe University of Sydney / Brain and Mind CentreVerified email at sydney.edu.au
Sudarshini RamanathanAssociate Professor of Neuroimmunology; Faculty of Medicine and Health, University of SydneyVerified email at sydney.edu.au
Simon BroadleyProfessor of Neurology, Griffith UniversityVerified email at griffith.edu.au
Heidi BeadnallClinical Lecturer, University of SydneyVerified email at sydneyneurology.com.au
Russell C DaleUniversity of SydneyVerified email at health.nsw.gov.au
Fabienne BrilotUniversity of SydneyVerified email at sydney.edu.au
Jeannette Lechner-ScottHunter Medical Research InstituteVerified email at health.nsw.gov.au
Steve VucicProfessor of Neurology, University of SydneyVerified email at sydney.edu.au
Anneke Van Der WaltAssociate Professor, Central Clinical School, Monash UniversityVerified email at monash.edu
Victor FungWestmead Hospital & University of SydneyVerified email at sydney.edu.au
Chenyu WangBrain and Mind Centre, University of Sydney; Sydney Neuroimaging Analysis CentreVerified email at sydney.edu.au
James BrockAssociate Professor, Dept of Anatomy and Neuroscience, Uni of MelbourneVerified email at unimelb.edu.au
Yael BarnettSt Vincent's Hospital Sydney, University of NSWVerified email at sydneyneurology.com.au
Stefan Blumuniversity of queenslandVerified email at uq.edu.au
Pamela McCombeThe University of QueenslandVerified email at uq.edu.au
Richard LeventerProfessor of Neurology, Royal Children's Hospital, MelbourneVerified email at rch.org.au
Wallace BrownleeQueen Square MS Centre, UCL Institute of NeurologyVerified email at ucl.ac.uk
Shekeeb S MohammadThe University of SydneyVerified email at uni.sydney.edu.au
Michael FulhamRoyal Prince Alfred (RPA) Hospital and the University of SydneyVerified email at sydney.edu.au
Prof David KavanaghProfessor of Complement Therapeutics, National Renal Complement Therapeutics CentreVerified email at ncl.ac.uk

Dr Todd A. Hardy

Consultant Neurologist, Concord Repatriation General Hospital

Verified email at med.usyd.edu.au

Neurology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Diagnosis of multiple sclerosis: progress and challenges WJ Brownlee, TA Hardy, F Fazekas, DH Miller The Lancet 389 (10076), 1336-1346, 2017	908	2017
Clinical course, therapeutic responses and outcomes in relapsing MOG-antibody associated demyelination DRC Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC ... Journal of Neurol Neurosurg Psychiatry, jnnp-2017-316880, 2017	543*	2017
C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy A Richards, AMJM Van Den Maagdenberg, JC Jen, D Kavanagh, ... Nature genetics 39 (9), 1068-1070, 2007	465	2007
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis S Ramanathan, K Prelog, EH Barnes, EM Tantsis, SW Reddel, ... Multiple Sclerosis Journal 22 (4), 470-482, 2016	366	2016
Tumefactive demyelination: an approach to diagnosis and management TA Hardy, J Chataway Journal of Neurology, Neurosurgery & Psychiatry 84 (9), 1047-1053, 2013	177	2013
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations AH Stam, PH Kothari, A Shaikh, A Gschwendter, JC Jen, S Hodgkinson, ... Brain 139 (11), 2909-2922, 2016	174	2016
Atypical inflammatory demyelinating syndromes of the CNS TA Hardy, SW Reddel, MH Barnett, J Palace, CF Lucchinetti, ... The Lancet Neurology 15 (9), 967-981, 2016	161	2016
Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathy S Ramanathan, D Langguth, TA Hardy, N Garg, C Bundell, ... Neuroimmunology & Neuroinflammation 2 (3), e96, 2015	135	2015
Baló's concentric sclerosis TA Hardy, DH Miller The Lancet Neurology 13 (7), 740-746, 2014	122	2014
CD8⁺ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome CC Gross, C Meyer, U Bhatia, L Yshii, I Kleffner, J Bauer, AR Tröscher, ... Nature communications 10 (1), 5779, 2019	119	2019
Guillain-Barré syndrome: modern theories of etiology TA Hardy, S Blum, PA McCombe, SW Reddel Current allergy and asthma reports 11, 197-204, 2011	93	2011
Effects of a selective neuropeptide Y Y₂ receptor antagonist, BIIE0246, on Y₂ receptors at peripheral neuroeffector junctions MA Smith‐White, TA Hardy, JA Brock, EK Potter British journal of pharmacology 132 (4), 861-868, 2001	88	2001
Long-term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD PSJ Wingerchuk DM, Fujihara, K, Palace, J, Berthele A, Levy M, Kim HJ ... Annals of Neurology, 2021	83	2021
The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases N Garg, SW Reddel, DH Miller, J Chataway, DS Riminton, Y Barnett, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (12), 1374-1382, 2015	82	2015
Posterior reversible encephalopathy syndrome (PRES): diagnosis and management JD Triplett, MA Kutlubaev, AG Kermode, T Hardy Practical Neurology 22 (3), 183-189, 2022	81	2022
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination Tea Acta Neuropathol Commun 7 (1), 145, 2019	81	2019
Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders S Rinaldi, A Davies, J Fehmi, HN Beadnall, J Wang, TA Hardy, ... Neurology: Neuroimmunology & Neuroinflammation 8 (1), e924, 2020	80	2020
The evolution of “No Evidence of Disease Activity” in multiple sclerosis G Lu, HN Beadnall, J Barton, TA Hardy, C Wang, MH Barnett Multiple sclerosis and related disorders 20, 231-238, 2018	78	2018
Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years MSBS Group Neurology, 2021	77	2021
Brain histopathology in three cases of Susac's syndrome: implications for lesion pathogenesis and treatment TA Hardy, B O'Brien, N Gerbis, MH Barnett, SW Reddel, J Brewer, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (5), 582-584, 2015	66	2015

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors